Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
9 May 2022Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
2,491,167-21%
663,000
$21.04
$13,949,234.00
SELL
28 Apr 2022Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
2,909,758-11%
375,000
$27.33
$10,247,870.00
SELL
18 Apr 2022Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
26,296-30%
11,500
$31.87
$366,530.44
BUY
22 Mar 2022Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
3,192,058+1%
50,000
$32.51
$1,625,488.80
SELL
21 Mar 2022Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
38,878-32%
18,437
$34.17
$629,987.06
SELL
17 Mar 2022Boxer Capital, LLC
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,142,058-15%
575,201
$35.25
$20,275,836.00
SELL
11 Mar 2022Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
3,500
$36.01
$126,034.99
SELL
1 Mar 2022McGrath Yvonne
Chief Scientific Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
10,000
$36.76
$367,570.00
SELL
23 Feb 2022Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
35,244-29%
14,500
$34.34
$497,904.88
SELL
11 Feb 2022Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
1,518-69%
3,500
$35.85
$125,458.50
SELL
25 Jan 2022Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
53,612-21%
14,500
$35.68
$517,378.12
SELL
14 Jan 2022Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
723-82%
3,500
$39.32
$137,613.60
SELL
4 Jan 2022MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,738,785-5%
146,685
$42.58
$6,246,049.50
SELL
4 Jan 2022GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,484,728-5%
245,469
$42.58
$10,452,334.00
SELL
4 Jan 2022MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,738,785-5%
146,685
$42.58
$6,246,049.50
SELL
3 Jan 2022Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
7,000
$51.90
$363,300.00
SELL
3 Jan 2022Boxer Capital, LLC
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,767,405-15%
700,000
$46.54
$32,575,644.00
SELL
3 Jan 2022Biniszkiewicz Detlev
Director
iTeos Therapeutics, Inc.
(ITOS)
0-100%
3,500
$51.90
$181,650.00
SELL
27 Dec 2021Gall Matthew
Chief Financial Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
14,429-25%
5,000
$46.45
$232,250.00
SELL
17 Dec 2021Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
7,000
$41.00
$287,000.00
SELL
10 Dec 2021Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
3,500
$34.50
$120,750.00
SELL
3 Dec 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,886,964-1%
49,831
$33.73
$1,680,611.10
SELL
3 Dec 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,732,696-1%
83,390
$33.73
$2,812,427.50
SELL
3 Dec 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,886,964-1%
49,831
$33.73
$1,680,611.10
SELL
2 Dec 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
78,349-36%
44,500
$44.54
$1,982,131.20
SELL
30 Nov 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,942,731-2%
83,519
$34.47
$2,878,562.50
SELL
30 Nov 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,826,021-2%
139,773
$34.47
$4,817,417.00
SELL
30 Nov 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,942,731-2%
83,519
$34.47
$2,878,562.50
SELL
26 Nov 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,019,118-0%
23,045
$35.18
$810,765.75
SELL
26 Nov 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,953,860-0%
38,566
$35.18
$1,356,825.00
SELL
26 Nov 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,019,118-0%
23,045
$35.18
$810,765.75
SELL
22 Nov 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
78,200-15%
14,500
$36.08
$523,160.03
SELL
18 Nov 2021Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
28,000
$34.50
$966,000.00
SELL
17 Nov 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,073,334-2%
77,455
$36.61
$2,835,263.00
SELL
17 Nov 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,044,587-2%
129,617
$36.61
$4,744,666.50
SELL
17 Nov 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,073,334-2%
77,455
$36.61
$2,835,263.00
SELL
1 Nov 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
76,437-21%
20,557
$28.55
$586,965.70
SELL
21 Oct 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
96,994-0%
196
$28.00
$5,488.02
SELL
15 Oct 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,134,991-0%
17,099
$27.45
$469,309.06
SELL
15 Oct 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,137,214-0%
28,615
$27.45
$785,384.40
SELL
15 Oct 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
97,190-1%
1,836
$28.01
$51,424.35
SELL
15 Oct 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,134,991-0%
17,099
$27.45
$469,309.06
SELL
12 Oct 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,152,090-1%
56,770
$27.21
$1,544,473.60
SELL
12 Oct 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,165,829-1%
95,002
$27.21
$2,584,606.00
SELL
12 Oct 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,152,090-1%
56,770
$27.21
$1,544,473.60
SELL
7 Oct 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,208,860-1%
51,993
$27.23
$1,415,546.20
SELL
7 Oct 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,260,831-1%
87,006
$27.23
$2,368,800.20
SELL
7 Oct 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,208,860-1%
51,993
$27.23
$1,415,546.20
SELL
1 Oct 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,260,853-0%
27,566
$27.05
$745,524.60
SELL
1 Oct 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,347,837-0%
46,130
$27.05
$1,247,589.50
SELL
1 Oct 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,260,853-0%
27,566
$27.05
$745,524.60
SELL
28 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,288,419-0%
21,506
$27.00
$580,662.00
SELL
28 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,393,967-0%
35,990
$27.00
$971,730.00
SELL
28 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,288,419-0%
21,506
$27.00
$580,662.00
SELL
23 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,309,925-1%
53,468
$27.76
$1,484,415.60
SELL
23 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,429,957-1%
89,476
$27.76
$2,484,094.00
SELL
23 Sep 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
99,026-6%
6,411
$28.14
$180,373.81
SELL
23 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,309,925-1%
53,468
$27.76
$1,484,415.60
SELL
21 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,363,393-0%
33,929
$27.50
$933,030.25
SELL
21 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,519,433-1%
56,779
$27.50
$1,561,393.60
SELL
21 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,363,393-0%
33,929
$27.50
$933,030.25
SELL
16 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,411,023-2%
91,254
$28.38
$2,590,097.00
SELL
16 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,599,142-2%
152,711
$28.38
$4,334,451.50
SELL
16 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,411,023-2%
91,254
$28.38
$2,590,097.00
SELL
14 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,489,567-1%
45,665
$27.70
$1,264,909.60
SELL
14 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,730,582-1%
76,417
$27.70
$2,116,733.00
SELL
14 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,489,567-1%
45,665
$27.70
$1,264,909.60
SELL
9 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,534,241-1%
57,640
$28.32
$1,632,261.50
SELL
9 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,805,340-1%
96,456
$28.32
$2,731,459.50
SELL
9 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,534,241-1%
57,640
$28.32
$1,632,261.50
SELL
7 Sep 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,592,821-1%
42,566
$29.03
$1,235,644.00
SELL
7 Sep 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,903,369-1%
71,232
$29.03
$2,067,786.00
SELL
7 Sep 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,592,821-1%
42,566
$29.03
$1,235,644.00
SELL
1 Sep 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
105,987-16%
20,252
$28.66
$580,518.00
SELL
27 Aug 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
125,689-10%
14,663
$28.13
$412,480.53
SELL
23 Aug 2021Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
140,352-5%
8,585
$28.06
$240,889.56
BUY
16 Jun 2021Gall Matthew
Chief Financial Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
5,000+100%
5,000
$26.09
$130,446.50
SELL
14 Jun 2021Detheux Michel
Chief Executive Officer, Director, Officer
iTeos Therapeutics, Inc.
(ITOS)
152,874-15%
29,000
$28.50
$826,534.10
SELL
8 Jun 2021McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
7,927
$20.00
$158,540.00
SELL
1 Jun 2021McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
7,927
$20.17
$159,902.62
SELL
24 May 2021McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0-100%
7,927
$21.92
$173,796.31
SELL
17 May 2021McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
2,119-78%
7,926
$24.69
$195,719.39
SELL
9 Apr 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,665,787-0%
119
$29.99
$3,568.81
SELL
9 Apr 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
6,004,368-0%
200
$29.99
$5,998.00
SELL
9 Apr 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,665,787-0%
119
$29.99
$3,568.81
SELL
7 Apr 2021MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,666,153-0%
25,087
$30.99
$777,343.00
SELL
7 Apr 2021GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
6,004,982-0%
41,982
$30.99
$1,300,850.40
SELL
7 Apr 2021MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,666,153-0%
25,087
$30.99
$777,343.00
BUY
28 Jul 2020MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887+8%
160,000
$19.00
$3,040,000.00
BUY
28 Jul 2020MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887+8%
160,000
$19.00
$3,040,000.00
BUY
28 Jul 2020Davis Aaron I.
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,345,016+48%
1,425,000
$19.00
$27,075,000.00
BUY
28 Jul 2020GADICKE ANSBERT
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887+18%
320,000
$19.00
$6,080,000.00
BUY
28 Jul 2020Boxer Capital, LLC
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,345,016+48%
1,425,000
$19.00
$27,075,000.00
BUY
28 Jul 2020RA CAPITAL MANAGEMENT, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,417,259+47%
1,425,000
$19.00
$27,075,000.00